Role of Anti-CD38 Monoclonal Antibodies in the Treatment of Adult Immune Hematological Diseases
Daratumumab is a first-in-class human anti-CD38 IgG1 monoclonal antibody approved for treating newly diagnosed and relapsed refractory multiple myeloma. Pre-clinical data supported daratumumab's ability to deplete autoantibodies producing plasma cells, B-cells, and NK cells. Those reports showed pro...
Guardado en:
| Autores principales: | , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Wolters Kluwer Medknow Publications
2024-01-01
|
| Colección: | Hematology/Oncology and Stem Cell Therapy |
| Materias: | |
| Acceso en línea: | https://journals.lww.com/10.56875/2589-0646.1108 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|